Wells Fargo’s AstraZeneca AZN Stock Holding History

Wells Fargo’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73M	Buy	14,400 +2,400	+20%	+$451K	﹤0.01%	3345
2026 Q1	$2.37M	Sell	12,000 -1,150	-9%	-$222K	﹤0.01%	3143
2025 Q4	$2.42M	Sell	13,150 -800	-6%	-$140K	﹤0.01%	3290
2025 Q3	$2.14M	Buy	13,950 +12,000	+615%	+$1.82M	﹤0.01%	3257
2025 Q2	$273K	Buy	+1,950	New	+$273K	﹤0.01%	4577
2025 Q1	–	Sell	-117,850	Closed	-$15.4M	–	7035
2024 Q4	$15.4M	Buy	+117,850	New	+$16.5M	﹤0.01%	1530
2023 Q1	–	Sell	-50,000	Closed	-$6.78M	–	7669
2022 Q4	$6.78M	Hold	50,000	–	–	﹤0.01%	1830
2022 Q3	$5.48M	Hold	50,000	–	–	﹤0.01%	1926
2022 Q2	$6.61M	Hold	50,000	–	–	﹤0.01%	1875
2022 Q1	$6.63M	Buy	50,000 +49,950	+99,900%	+$5.99M	﹤0.01%	2203
2021 Q4	$6K	Buy	+50	New	+$5.88K	﹤0.01%	6660
2021 Q1	–	Sell	-37,500	Closed	-$568K	–	6875
2020 Q4	$568K	Sell	37,500 -7,500	-17%	-$794K	﹤0.01%	4430
2020 Q3	$431K	Buy	45,000 +7,200	+19%	+$801K	﹤0.01%	4457
2020 Q2	$93K	Buy	+37,800	New	+$3.9M	﹤0.01%	5252
2017 Q3	–	Sell	-3,600	Closed	-$7K	–	6303
2017 Q2	$7K	Buy	+3,600	New	+$235K	﹤0.01%	5848
2015 Q1	–	Sell	-250,000	Closed	-$52K	–	6159
2014 Q4	$52K	Hold	250,000	–	–	﹤0.01%	4997
2014 Q3	$263K	Hold	250,000	–	–	﹤0.01%	4228
2014 Q2	$18.6M	Buy	+250,000	New	+$18.1M	0.01%	1348

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wells Fargo's AZN Position: Q2 2026 in Review

Wells Fargo increased its AstraZeneca (AZN) stake by 3.4% in Q2 2026, buying an estimated $9.74M and bringing the position to 1,596,427 shares worth $303M. The position accounts for 0.05% of the portfolio, ranked #316.

Wells Fargo first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $305M in Q1 2026. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Wells Fargo held 1,596,427 shares of AstraZeneca worth $303M as of Q2 2026.
Wells Fargo bought 51,795 AstraZeneca shares in Q2 2026, an estimated $9.74M.
AstraZeneca made up 0.05% of Wells Fargo's portfolio in Q2 2026, its #316 holding.
Wells Fargo first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
Wells Fargo's AstraZeneca position peaked at $305M in Q1 2026.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.